BNT411

Overview

BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro . BNT411 has anticancer activity and can be used in cancer research, including non-small cell lung cancer , pancreatic cancer , and untreated extensive-stage small cell lung cancer (ES-SCLC).

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Pancreatic Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Toll-like Receptor (TLR)

Product Information

• Catalog No.: HY-160715
• CAS No.: 2296821-50-4
• Molecular Formula: C24H33N5O3
• Molecular Weight: 439.55
• Purity: 99.01%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source